The novel approach of the medication represents a exciting development in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone https://tirzepatide-peptide200009.bleepblogs.com/42319098/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment